EADV Congress 2025 – Hair and Nail Disorders Abstract Book

Conference Research on Androgen Receptor Regulation in Female Pattern Hair Loss

A clinical research abstract presented at the EADV Congress 2025 reported findings from a randomised, double-blind, placebo-controlled study investigating an androgen-receptor-regulating topical approach in women with female pattern hair loss.

The study explored whether modulation of androgen receptor expression could improve hair growth outcomes in individuals who do not respond adequately to conventional therapies. Changes in scalp biomarkers and hair growth parameters were evaluated over a multi-month treatment period using standard clinical assessment methods.

According to the presented data, the investigational treatment group demonstrated statistically significant improvements in hair density compared with the placebo group, while no notable safety concerns were reported during the study period.

This conference presentation highlights the growing scientific interest in androgen receptor–targeted strategies as a potential new direction for the management of female androgenetic alopecia.

Source (conference abstract):
EADV Congress 2025 – Hair and Nail Disorders Abstract Book (PDF)

This content is provided for informational purposes only. The above text is an independent editorial summary and does not reproduce or substitute the original conference abstract. It is not intended to diagnose, treat, cure, or prevent any medical condition.